Cyclerion Therapeutics, Inc. (CYCN) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 4.1M |
| Enterprise Value | 855,747 |
| P/E Ratio | -2.65 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | 78.61 |
| Price/Book Ratio | 3.81 |
| Enterprise/Revenue | 77.88 |
| Enterprise/EBITDA | -22.06 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -3.53 |
| Operating Margin | -3.59 |
| Return On Assets | -0.97 |
| Return On Equity | -0.88 |
| Revenue | 2.07M |
| Revenue/Share | 3.13 |
| Gross Profit | 2.07M |
| EBITDA | -3.53M |
| Net Income | -3.53M |
| Diluted EPS | -7.63 |
| Total Cash | 1.39M |
| Total Cash/Share | 2.29 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0.82 |
| Book Value Per Share | 8.38 |
| 52-Week Change | 31.76 |
| 52-Week High | 59.36 |
| 52-Week Low | 2.82 |
| Moving Average 50 Days | 26.37 |
| Moving Average 200 Days | 18.35 |
| Average Volume | 6,746 |
| Shares Outstanding | 668,764 |
| % Held by Institutions | 77.59 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | May 16, 2023 |